Alpha Cognition Inc. (ACOG) Operating Margin
- Operating margin · 12 months: Value -174.70%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -174.70% | Operating income / revenue. Period ending 2026-06-30. $-26.66M ÷ $15.26M × 100 ≈ -174.70% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -26.66M USD | Operating Income (Loss) |
| Revenue | 15.26M USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 4.17M USD | Research and Development Expense |
| Selling, general and administration | 36.20M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-26.66M | $15.26M | (m) | $4.17M | $36.20M | -174.70% |
| 2026-03-31 | $-27.35M | $10.83M | (m) | $2.56M | $34.24M | -252.66% |
| 2025-12-31 | $-22.66M | $10.22M | $603.40K | $1.87M | $29.08M | -221.72% |
| 2025-09-30 | $-17.28M | (m) | (m) | $2.34M | (m) | (m) |
| 2025-06-30 | $-14.45M | (m) | (m) | $2.76M | (m) | (m) |
| 2025-03-31 | $-11.14M | (m) | (m) | $3.41M | (m) | (m) |
| 2024-12-31 | $-11.86M | (m) | (m) | $3.92M | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-9.94M | (m) | (m) | $4.88M | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |